GD2-targeted autologous CAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GD2-targeted autologous CAR T cells, covering 2026-02-05 to 2026-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer [EARLY_Phase 1]